Induction of complete remission of hypoplastic leukemia with antithymocyte globulin

Ayami Yoshimi, Chikako Nakamoto, Yoichi Nakamura, Koji Kato, Takaharu Matsuyama, Kazuko Kudo, Seiji Kojima

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A 13-year-old boy was admitted to a local hospital because of pancytopenia. A bone marrow aspiration and biopsy revealed severely hypocellular marrow with no obvious leukemic cells. The diagnosis was severe aplastic anemia, and the patient was treated with antithymocyte globulin and cyclosporin A. A trilineage response was obtained, and the patient became transfusion-independent within 2 weeks. Two months later, the peripheral blood count normalized with an increased bone marrow cellularity. However, the patient was readmitted 5 months later for recurrence of the pancytopenia. A bone marrow aspiration revealed hypocellular marrow with morphologically blastoid cells. A surface marker study revealed the presence of a single clone that was positive for CD7, CD33, CD34, and HLA-DR. A diagnosis of hypoplastic leukemia was made on the basis of morphology and the surface marker studies. Retrospectively, the laboratory findings were the same as those seen at the onset of the disease. The patient did not respond to combination chemotherapy consisting of vincristine, prednisolone, cyclophosphamide, L-asparaginase, and doxorubicin, but administration of etoposide resulted in complete remission. An in vitro study revealed that >95% of the leukemic cells of this patient could be lysed after an incubation with antithymocyte globulin and human AB serum or baby rabbit serum. These findings suggest the efficacy of antithymocyte globulin in treating certain hypoplastic leukemias.

Original languageEnglish
Pages (from-to)277-281
Number of pages5
JournalInternational journal of hematology
Volume77
Issue number3
DOIs
Publication statusPublished - Jan 1 2003
Externally publishedYes

Fingerprint

Remission Induction
Antilymphocyte Serum
Leukemia
Bone Marrow
Pancytopenia
Asparaginase
Aplastic Anemia
Needle Biopsy
Vincristine
HLA-DR Antigens
Etoposide
Prednisolone
Combination Drug Therapy
Serum
Doxorubicin
Cyclophosphamide
Cyclosporine
Clone Cells
Rabbits
Recurrence

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Induction of complete remission of hypoplastic leukemia with antithymocyte globulin. / Yoshimi, Ayami; Nakamoto, Chikako; Nakamura, Yoichi; Kato, Koji; Matsuyama, Takaharu; Kudo, Kazuko; Kojima, Seiji.

In: International journal of hematology, Vol. 77, No. 3, 01.01.2003, p. 277-281.

Research output: Contribution to journalArticle

Yoshimi, A, Nakamoto, C, Nakamura, Y, Kato, K, Matsuyama, T, Kudo, K & Kojima, S 2003, 'Induction of complete remission of hypoplastic leukemia with antithymocyte globulin', International journal of hematology, vol. 77, no. 3, pp. 277-281. https://doi.org/10.1007/BF02983786
Yoshimi, Ayami ; Nakamoto, Chikako ; Nakamura, Yoichi ; Kato, Koji ; Matsuyama, Takaharu ; Kudo, Kazuko ; Kojima, Seiji. / Induction of complete remission of hypoplastic leukemia with antithymocyte globulin. In: International journal of hematology. 2003 ; Vol. 77, No. 3. pp. 277-281.
@article{a8000ea37c9c4e018541316b619c6fd7,
title = "Induction of complete remission of hypoplastic leukemia with antithymocyte globulin",
abstract = "A 13-year-old boy was admitted to a local hospital because of pancytopenia. A bone marrow aspiration and biopsy revealed severely hypocellular marrow with no obvious leukemic cells. The diagnosis was severe aplastic anemia, and the patient was treated with antithymocyte globulin and cyclosporin A. A trilineage response was obtained, and the patient became transfusion-independent within 2 weeks. Two months later, the peripheral blood count normalized with an increased bone marrow cellularity. However, the patient was readmitted 5 months later for recurrence of the pancytopenia. A bone marrow aspiration revealed hypocellular marrow with morphologically blastoid cells. A surface marker study revealed the presence of a single clone that was positive for CD7, CD33, CD34, and HLA-DR. A diagnosis of hypoplastic leukemia was made on the basis of morphology and the surface marker studies. Retrospectively, the laboratory findings were the same as those seen at the onset of the disease. The patient did not respond to combination chemotherapy consisting of vincristine, prednisolone, cyclophosphamide, L-asparaginase, and doxorubicin, but administration of etoposide resulted in complete remission. An in vitro study revealed that >95{\%} of the leukemic cells of this patient could be lysed after an incubation with antithymocyte globulin and human AB serum or baby rabbit serum. These findings suggest the efficacy of antithymocyte globulin in treating certain hypoplastic leukemias.",
author = "Ayami Yoshimi and Chikako Nakamoto and Yoichi Nakamura and Koji Kato and Takaharu Matsuyama and Kazuko Kudo and Seiji Kojima",
year = "2003",
month = "1",
day = "1",
doi = "10.1007/BF02983786",
language = "English",
volume = "77",
pages = "277--281",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Induction of complete remission of hypoplastic leukemia with antithymocyte globulin

AU - Yoshimi, Ayami

AU - Nakamoto, Chikako

AU - Nakamura, Yoichi

AU - Kato, Koji

AU - Matsuyama, Takaharu

AU - Kudo, Kazuko

AU - Kojima, Seiji

PY - 2003/1/1

Y1 - 2003/1/1

N2 - A 13-year-old boy was admitted to a local hospital because of pancytopenia. A bone marrow aspiration and biopsy revealed severely hypocellular marrow with no obvious leukemic cells. The diagnosis was severe aplastic anemia, and the patient was treated with antithymocyte globulin and cyclosporin A. A trilineage response was obtained, and the patient became transfusion-independent within 2 weeks. Two months later, the peripheral blood count normalized with an increased bone marrow cellularity. However, the patient was readmitted 5 months later for recurrence of the pancytopenia. A bone marrow aspiration revealed hypocellular marrow with morphologically blastoid cells. A surface marker study revealed the presence of a single clone that was positive for CD7, CD33, CD34, and HLA-DR. A diagnosis of hypoplastic leukemia was made on the basis of morphology and the surface marker studies. Retrospectively, the laboratory findings were the same as those seen at the onset of the disease. The patient did not respond to combination chemotherapy consisting of vincristine, prednisolone, cyclophosphamide, L-asparaginase, and doxorubicin, but administration of etoposide resulted in complete remission. An in vitro study revealed that >95% of the leukemic cells of this patient could be lysed after an incubation with antithymocyte globulin and human AB serum or baby rabbit serum. These findings suggest the efficacy of antithymocyte globulin in treating certain hypoplastic leukemias.

AB - A 13-year-old boy was admitted to a local hospital because of pancytopenia. A bone marrow aspiration and biopsy revealed severely hypocellular marrow with no obvious leukemic cells. The diagnosis was severe aplastic anemia, and the patient was treated with antithymocyte globulin and cyclosporin A. A trilineage response was obtained, and the patient became transfusion-independent within 2 weeks. Two months later, the peripheral blood count normalized with an increased bone marrow cellularity. However, the patient was readmitted 5 months later for recurrence of the pancytopenia. A bone marrow aspiration revealed hypocellular marrow with morphologically blastoid cells. A surface marker study revealed the presence of a single clone that was positive for CD7, CD33, CD34, and HLA-DR. A diagnosis of hypoplastic leukemia was made on the basis of morphology and the surface marker studies. Retrospectively, the laboratory findings were the same as those seen at the onset of the disease. The patient did not respond to combination chemotherapy consisting of vincristine, prednisolone, cyclophosphamide, L-asparaginase, and doxorubicin, but administration of etoposide resulted in complete remission. An in vitro study revealed that >95% of the leukemic cells of this patient could be lysed after an incubation with antithymocyte globulin and human AB serum or baby rabbit serum. These findings suggest the efficacy of antithymocyte globulin in treating certain hypoplastic leukemias.

UR - http://www.scopus.com/inward/record.url?scp=0141680851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141680851&partnerID=8YFLogxK

U2 - 10.1007/BF02983786

DO - 10.1007/BF02983786

M3 - Article

C2 - 12731672

AN - SCOPUS:0141680851

VL - 77

SP - 277

EP - 281

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 3

ER -